The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1227
January 30, 2006
View Complete Issue         Table of Contents 2019 
Pioglitazone/Metformin (Actoplus met)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Pioglitazone/Metformin (Actoplus met)
January 30, 2006 (Issue: 1227)
For patients with diabetes poorly controlled with a single oral drug, addition of a second drug with a different mechanism can be helpful. A fixed-dose combination (Actoplus met - Takeda) of two widely used antihyperglycemic drugs, the...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Pioglitazone/Metformin (Actoplus met)
Article code: 1227a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.